Teive Hélio A G, Ferreira Matheus Gomes, Camargo Carlos Henrique F, Munhoz Renato P
Movement Disorders Unit, Neurology Service, Internal Medicine Department, Hospital de Clínicas, Federal University of Paraná, Curitiba, Paraná, Brazil.
Neurology Diseases Group, Postgraduate Program of Internal Medicine, Hospital de Clínicas, Federal University of Paraná, Curitiba, Paraná, Brazil.
Parkinsons Dis. 2020 Oct 29;2020:8860785. doi: 10.1155/2020/8860785. eCollection 2020.
Patients with advanced stage Parkinson's disease (PD) typically present with a myriad of motor and nonmotor symptoms in addition to comorbidities and, as a consequence, polypharmacy.
To analyze a series of cases of advanced PD in which a clinical or surgical emergency played a trigger role in the irreversible progression of landmarks of the course of the disease.
Data were collected during a 13-month observational period of a cohort of 230 PD patients, in 751 medical appointments. We included a total of 13 (5.65% of the total number) patients with advanced PD defined by Hoehn & Yahr (H&Y) stage ≥3 who presented with various clinical and surgical complications which, with the contribution of drug interventions, led to significant worsening of patients' overall clinical condition.
Hip fractures and infections were the most common complications identified. As part of this scenario, most patients presented with delirium, often requiring treatment with dopamine receptor blocking agents and/or had dopaminergic treatment withdrawn. Upon reassessment after 3 months, all patients remained bed or wheel chair bound (H&Y 5) and presented significant worsening of their UPDRS part III score of at least 10 points (mean 51.5 ± 3.3; paired -test two-tailed < 0.0001 compared to baseline). The mean dose of levodopa at baseline was 907.7 ± 149.8 mg (600-1200) and significantly higher (paired -test two-tailed < 0.0001) on follow-up, 1061.5 ± 175.8 mg (700-1300).
Clinical and surgical emergencies are major determinants for a progression of PD to more advanced stages.
晚期帕金森病(PD)患者除了合并症外,通常还伴有多种运动和非运动症状,因此存在多药联用的情况。
分析一系列晚期PD病例,其中临床或外科急症在疾病进程的不可逆进展中起触发作用。
在13个月的观察期内,对230例PD患者进行了751次医疗预约,收集相关数据。我们纳入了总共13例(占总数的5.65%)由Hoehn & Yahr(H&Y)分期≥3定义的晚期PD患者,这些患者出现了各种临床和外科并发症,在药物干预的作用下,导致患者整体临床状况显著恶化。
髋部骨折和感染是最常见的并发症。在这种情况下,大多数患者出现谵妄,常常需要使用多巴胺受体阻滞剂进行治疗和/或停用多巴胺能治疗。3个月后重新评估时,所有患者仍需卧床或依赖轮椅(H&Y 5期),其统一帕金森病评定量表(UPDRS)第三部分评分显著恶化至少10分(平均51.5±3.3;与基线相比,配对双尾检验<0.0001)。基线时左旋多巴的平均剂量为907.7±149.8 mg(600 - 1200),随访时显著更高(配对双尾检验<0.0001),为1061.5±175.8 mg(700 - 1300)。
临床和外科急症是PD进展至更晚期阶段的主要决定因素。